LD 423 | CAS 58336-37-1

Catalog Number	A17-0102
Category	Laser Dyes
Molecular Formula	C16H20N2O
Molecular Weight	256.34

Inquiry

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Worldwide Delivery
Quality Assurance
24/7 Customer Service

Product Introduction

LD 423 provides green fluorescence for cell-membrane and organelle staining. It’s ideal for tracking morphological changes in live-cell imaging.

Chemical Information
Application

Synonyms	1,2,3,8-tetrahydro-1,2,3,3,5-pentamethyl-7H-pyrrolo[3,2-g]quinolin-7-one
Canonical SMILES	CC1C(C2=C(N1C)C=C3C(=C2)C(=CC(=O)N3)C)(C)C
InChI	InChI=1S/C16H20N2O/c1-9-6-15(19)17-13-8-14-12(7-11(9)13)16(3,4)10(2)18(14)5/h6-8,10H,1-5H3,(H,17,19)
InChIKey	CMSOFVRQNSYALT-UHFFFAOYSA-N
Appearance	Pale White Crystals

LD 423 is a cutting-edge therapeutic compound recognized for its targeted inhibition of dipeptidyl peptidase-4 (DPP-4), an enzyme critical in the regulation of blood glucose levels. This specificity allows it to play a significant role in managing Type 2 diabetes by enhancing insulin secretion and suppressing glucagon release, both crucial for maintaining optimal blood sugar balance. By efficiently controlling these mechanisms, LD 423 significantly improves the quality of life for patients dealing with this chronic condition.

One of the primary applications of LD 423 is in improving the management of Type 2 diabetes. By increasing the body’s ability to produce insulin, it effectively reduces high blood glucose levels, a fundamental problem in diabetes care. This action minimizes the risk of acute complications and long-term damage, thus offering an improved prognosis for individuals affected by this disease.

Another critical application of LD 423 is its role in preventing the escalation of prediabetes to Type 2 diabetes. Through its glucose-regulating effects, LD 423 helps maintain blood sugar levels within a normal range in individuals who are at high risk, potentially delaying or preventing the onset of diabetes. This preemptive approach is crucial for reducing the burden of diabetes on healthcare systems worldwide.

Additionally, LD 423 is explored for its potential benefits in cardiovascular protection. Given the strong link between Type 2 diabetes and heart disease, the compound’s ability to enhance glycemic control may indirectly support heart health by reducing diabetes-related complications. Ongoing studies are focused on establishing its efficacy in this preventive application.

Lastly, LD 423 may offer neuroprotective benefits due to its regulatory effects on glucose metabolism. Proper glucose management is linked to brain health, and LD 423’s role in maintaining stable blood glucose levels can be crucial in preventing cognitive decline associated with diabetes. This emerging application highlights the compound’s multifaceted potential beyond merely managing blood sugar.